Analysis of dextrorphan, a metabolite of dextromethorphan, using gas chromatography with electron-capture detection

Journal of Pharmacological and Toxicological Methods

Volumn 41, Issue 4, 1999, Pages 143-146

  Salsali, Mahnaz ^a   Coutts, Ronald T ^a   Baker, Glen B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Dextromethorphan; Dextrorphan; Electron capture gas chromatography; Pentafluorobenzoyl chloride

Indexed keywords

CYTOCHROME P450; DEXTROMETHORPHAN; DEXTRORPHAN;

ARTICLE; DERIVATIZATION; DRUG DETERMINATION; ELECTRON CAPTURE DETECTION; EXTRACTION; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER MICROSOME METABOLISM; MASS SPECTROMETRY;

BENZOATES; CHROMATOGRAPHY, GAS; DEXTRORPHAN; DRUG STABILITY; HUMANS; MEPHENYTOIN; MICROSOMES, LIVER; OXIDATION-REDUCTION; SOLUBILITY;

EID: 0033395031     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(99)00033-7     Document Type: Article

References (33)

1. Achamallah N.S. Visual hallucination after combining fluoxetine and dextromethorphan. Am J Psychiatry. 194:1992;1406.
2. Baumann P., Jonzier-Perey M. GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin. Clin Chim Acta. 171:1988;211-222.
3. Butler K. Opinion. letters Can Pharm J. 127:1994;271.
4. Caslavska J., Hufschmid E., Theurillat R., Desiderio C., Wolfisberg H., Thormann W. Screening for hydroxylation and acetylation polymorphisms in man via simultaneous analysis of urinary metabolites of mephenytoin, dextromethorphan and caffeine by capillary electrophoretic procedures. J Chromatiogr B Biomed Appl. 656:1994;219-231.
5. Chen Z.R., Somogyi A.A., Bochner F. Simultaneous determination of dextromethorphan and three metabolites in plasma and urine using high-performance liquid chromatography with application to their disposition in man. Ther Drug Monit. 12:1990;97-104.
6. Cristofoli W.A., Baker G.B., Coutts R.T., Benderly A. Analysis of a monofluorinated analogue of amphetamine in brain tissue using gas chromatography with electron-capture detection. Prog Neuropsychopharmacol Biol Psychiatry. 6:1982;373.
7. East T., Dye D. Determination of dextromethorphan and metabolites in human plasma and urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 338:1985;99-112.
8. Evans W.E., Relling M.V., Petros W.P., Meyer W.H., Mirro J. Jr., Crom W.R. Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children. Clin Pharmacol Ther. 45:1989;568-573.
9. Gaertner R. Opinion. letters Can Pharmaceut J. 127:1994;271.
10. Guttendorf R.J., Wedlund P.J., Blake J., Chang S.L. Simplified phenotyping with dextromethorphan by thin-layer chromatography. application to clinical laboratory screening for deficiencies in oxidative drug metabolism Ther Drug Monit. 10:1988;490-498.
11. Henderson M.G., Fuller R.W. Dextromethorphan antagonizes the acute depletion of brain serotonin by p-chloroamphetamine and H75/12 in rats. Brain Res. 594:1992;323-326.
12. Jacqz-Aigran E., Funck-Bretano C., Cresteil T. CYP2D6 and CYP3A-dependent metabolism of dextromethorphan in humans. Pharmacogenetics. 3:1993;197-204.
13. Kiivet R.A., Svensson J.O., Bertilsson L., Sjoqvist F. Polymorphism of debrisoquine and mephenytoin hydroxylation among Estonians. Pharmacol Toxicol. 72:1993;113-115.
14. Kintz P., Mangin P., Lugnier A., Chaumont A.J. Determination of dextromethorphan and its major metabolite dextrorphan by gas chromatography. Ann Biol Clin (Paris). 47:1989;193-195.
15. Kronbach T. Bufuralol, dextromethorphan, and debrisoquine as prototype substrates for human P450 2D6. Methods Enzymol. 206:1991;509-517.
16. 1-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Anal Biochem. 162:1987;24-32.
17. Kupfer A., Schmid B., Preisig R., Pfaff G. Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism. Lancet. 2:1984;517-518.
18. Lam Y.W., Rodriguez S.Y. High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection. Ther Drug Monit. 15:1993;300-304.
19. Mistry B., Leslie J., Eddington N.E. A sensitive assay of metoprolol and its major metabolite alpha-hydroxymetoprolol in human plasma and determination of dextromethorphan and its metabolite dextrorphan in urine with high performance liquid chromatography and fluorometric detection. J Pharm Biomed Anal. 16:1998;1041-1049.
20. Nazarali A.J., Baker G.B., Boisvert D.P. Metabolism and disposition of N-(2-cyanoethyl)amphetamine (fenproporex) and amphetamine. study in the rat brain J Chromatogr B Biomed Appl. 380:1986;393-400.
21. Nazarali A.J., Baker G.B., Coutts R.T., Greenshaw A.J. Para-hydroxytranylcypromine. presence in rat brain and heart following administration of tranylcypromine and an N-cyanoethyl analogue Eur J Drug Metab Pharmacokinet. 12:1987;207-214. a.
22. Nazarali A.J., Baker G.B., Coutts R.T., Pasutto F.M., Cristofoli W.A. Simultaneous analysis of N-(2-cyanoethyl)amphetamine (fenproporex), amphetamine and para-hydroxyamphetamine in rat brain. Res Commun Subst Abuse. 5:1984;317-320.
23. Nazarali A.J., Baker G.B., Coutts R.T., Yeung J.M., Rao T.S. Rapid analysis of 2-phenylethylamine in tissues and body fluids utilizing pentafluorobenzoylation followed by electron-capture gas chromatography. Prog Neuropsychopharmacol Biol Psychiatry. 11:1987;251-258. b.
24. Nierenberg D.W., Semprebon M. The central nervous system serotonin syndrome. Clin Pharmacol Ther. 53:1993;84-88.
25. Park Y.H., Kullberg M.P., Hinsvark O.N. Quantitative determination of dextromethorphan and three metabolites in urine by reverse-phase high-performance liquid chromatography. J Pharm Sci. 73:1984;24-29.
26. Rao T.S., Baker G.B., Coutts R.T., Yeung J.M., McIntosh G.J.A., Torok-Both G.A. Analysis of the antidepressant phenelzine in brain tissue and urine using electron-capture gas chromatography. J Pharmacol Methods. 17:1987;297-304.
27. Reisine, T., & Pasternak, G. (1996). Opioid analgesics and antagonists. In J. Hardman, L. Limbird, P.B. Molinoff, R.W. Ruddon, & A. Goodman Gilman (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics. (p. 551) New York: McGraw-Hill.
28. 14C] dextromethorphan as substrate. Methods Enzymol. 272:1996;186-195.
29. Schmid B., Bircher J., Preisig R., Kupfer A. Polymorphic dextromethorphan metabolism. co-segregation of oxidative O-demethylation with debrisoquin hydroxylation Clin Pharmacol Ther. 38:1985;618-624.
30. Skop B.P., Finkelstein J.A., Mareth T.R., Magoon M.R., Brown T.M. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med. 12:1994;642-644.
31. Stavchansky S., Demirbas S., Reyderman L., Chai C.K. Simultaneous determination of dextrorphan and guaifenesin in human plasma by liquid chromatography with fluorescence detection. J Pharm Biomed Anal. 13:1995;919-925.
32. Vielnascher E., Spatzenegger M., Mayrhofer A., Klinger P., Jager W. Metabolism of dextromethorphan in human liver microsomes. a rapid HPLC assay to monitor cytochrome P450 2D6 activity Pharmazie. 51:1996;586-588.
33. Von Moltke L., Greenblatt D.J., Grassi J.M., Granda B.W., Venkatakrishnan K., Schmider J., Harmatz J.S. Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro. role of CYP2C9, CYP2C19, CYP2D6, and CYP3A J Pharm Pharmacol. 50:1998;997-1004.